Probiotics, prebiotics and their role in Alzheimer's disease  

作　　者：Valeria D’Argenio Daniela Sarnataro 

机构地区：[1]Department of Human Sciences and Quality of Life Promotion,San Raffaele Open University,Roma,Italy [2]CEINGE-Biotecnologie Avanzate,Naples,Italy [3]Department of Molecular Medicine and Medical Biotechnologies,University of Naples Federico II,Naples,Italy

出　　处：《Neural Regeneration Research》2021年第9期1768-1769,共2页中国神经再生研究（英文版）

摘　　要：Accumulation of amyloid and dysfunctional tau proteins in the brain, along with the development of dementia, characterizes Alzheimer 's disease(AD). Although the cause of AD is currently unknown, it has been shown that the onset of the disease, with amyloid-beta peptide(Aβ) accumulation, occurs 10–20 years before the development of the clinical signs.

关 键 词：ALZHEIMER TAU AΒ 

分 类 号：R749.16[医药卫生—神经病学与精神病学]